GlassScriptPhysician profile
Marilene Wang
NPI 1922111863
$16,132.15
in general payments reported to CMS, 2019-2025
24 companies · $2,165 in 2025
The $2,165 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,558 · 2020: $2,551 · 2021: $1,729 · 2022: $3,436 · 2023: $2,097 · 2024: $2,596 · 2025: $2,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,426 · Consulting Fee: $406 · Travel and Lodging: $26.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,426.16 |
| Consulting Fee | $405.95 |
| Travel and Lodging | $26.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,151.07 | 2019-2025 | Scopis Ent, Audion Et Dilation System, Fiagon Navigation Unit |
| Aerin Medical INC. | $4,021.71 | 2019-2025 | |
| Medtronic, INC. | $1,423.55 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Intuitive Surgical, INC. | $927.72 | 2019-2020 | |
| Optinose US, INC. | $860.44 | 2019-2023 | |
| Acclarent, INC | $739.09 | 2019-2023 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $600.05 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Intersect Ent, INC. | $473.78 | 2019-2021 | |
| Neurent Medical Limited | $434.64 | 2022-2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Regeneron Pharmaceuticals, INC. | $400.49 | 2025 | Dupixent, Libtayo |
| Musculoskeletal Transplant Foundation INC. | $344.86 | 2024 | |
| Medtronic USA, INC. | $298.79 | 2020 | |
| Smith+Nephew, INC. | $268.40 | 2021-2024 | |
| Karl Storz Endoscopy-America | $186.76 | 2022 | |
| Becton, Dickinson and Company | $137.90 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $130.32 | 2025 | |
| Baxter Healthcare | $128.78 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $121.54 | 2023 | Dupixent |
| Genzyme Corporation | $121.35 | 2019 | |
| Cook Medical LLC | $105.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $100.73 | 2020 | |
| Glaxosmithkline, LLC. | $66.07 | 2021 | |
| Alk-Abello, INC | $62.24 | 2021 | |
| Amgen INC. | $26.71 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilene Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.